311 related articles for article (PubMed ID: 9549720)
1. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.
Notkola IL; Sulkava R; Pekkanen J; Erkinjuntti T; Ehnholm C; Kivinen P; Tuomilehto J; Nissinen A
Neuroepidemiology; 1998; 17(1):14-20. PubMed ID: 9549720
[TBL] [Abstract][Full Text] [Related]
2. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.
González C; Martín T; Cacho J; Breñas MT; Arroyo T; García-Berrocal B; Navajo JA; González-Buitrago JM
Eur J Clin Invest; 1999 Jul; 29(7):637-42. PubMed ID: 10411671
[TBL] [Abstract][Full Text] [Related]
3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
4. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study.
Jarvik GP; Wijsman EM; Kukull WA; Schellenberg GD; Yu C; Larson EB
Neurology; 1995 Jun; 45(6):1092-6. PubMed ID: 7783869
[TBL] [Abstract][Full Text] [Related]
5. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.
Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T
Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023
[TBL] [Abstract][Full Text] [Related]
7. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.
Steffens DC; Plassman BL; Helms MJ; Welsh-Bohmer KA; Saunders AM; Breitner JC
Biol Psychiatry; 1997 Apr; 41(8):851-6. PubMed ID: 9099411
[TBL] [Abstract][Full Text] [Related]
8. Serum lipoprotein profile and APOE genotype in Alzheimer's disease.
Cagnin A; Zambon A; Zarantonello G; Vianello D; Marchiori M; Mercurio D; Miccichè F; Ermani M; Leon A; Battistin L
J Neural Transm Suppl; 2007; (72):175-9. PubMed ID: 17982892
[TBL] [Abstract][Full Text] [Related]
9. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.
Dupuy AM; Mas E; Ritchie K; Descomps B; Badiou S; Cristol JP; Touchon J
Gerontology; 2001; 47(4):213-8. PubMed ID: 11408727
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
Kivipelto M; Helkala EL; Laakso MP; Hänninen T; Hallikainen M; Alhainen K; Iivonen S; Mannermaa A; Tuomilehto J; Nissinen A; Soininen H
Ann Intern Med; 2002 Aug; 137(3):149-55. PubMed ID: 12160362
[TBL] [Abstract][Full Text] [Related]
11. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.
Tan ZS; Seshadri S; Beiser A; Wilson PW; Kiel DP; Tocco M; D'Agostino RB; Wolf PA
Arch Intern Med; 2003 May; 163(9):1053-7. PubMed ID: 12742802
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians.
Panza F; Solfrizzi V; Colacicco AM; Basile AM; D'Introno A; Capurso C; Sabba M; Capurso S; Capurso A
Neuroreport; 2003 Mar; 14(4):605-8. PubMed ID: 12657895
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease.
Hirono N; Mori E; Yasuda M; Imamura T; Shimomura T; Hashimoto M; Tanimukai S; Kazui H; Yamashita H
J Neuropsychiatry Clin Neurosci; 1999; 11(1):66-70. PubMed ID: 9990558
[TBL] [Abstract][Full Text] [Related]
14. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.
Corder EH; Saunders AM; Risch NJ; Strittmatter WJ; Schmechel DE; Gaskell PC; Rimmler JB; Locke PA; Conneally PM; Schmader KE
Nat Genet; 1994 Jun; 7(2):180-4. PubMed ID: 7920638
[TBL] [Abstract][Full Text] [Related]
16. Genotypes with the apolipoprotein epsilon4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men.
Stengård JH; Pekkanen J; Ehnholm C; Nissinen A; Sing CF
Hum Genet; 1996 May; 97(5):677-84. PubMed ID: 8655152
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.
Holmes C; Russ C; Kirov G; Aitchison KJ; Powell JF; Collier DA; Lovestone S
Biol Psychiatry; 1998 Feb; 43(3):159-64. PubMed ID: 9494696
[TBL] [Abstract][Full Text] [Related]
19. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease.
Isbir T; Agaçhan B; Yilmaz H; Aydin M; Kara I; Eker E; Eker D
Am J Alzheimers Dis Other Demen; 2001; 16(2):77-81. PubMed ID: 11302074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
